Ludhiana Drug Control Department Intensifies Crackdown on Illegal Pharmaceutical Stocks
The Drug Control Department (DCD) in Ludhiana has significantly ramped up its enforcement efforts against illegal pharmaceutical activities, uncovering a major violation at a medical store in the Kaneja area. Acting on a credible tip-off, the department conducted a thorough inspection to verify compliance with the Drugs and Cosmetics Act, 1940, and its associated regulations.
Operation Led by Drugs Control Officer
The operation was executed under the supervision of Navdeep Sandhu, the drugs control officer for Ludhiana-3. During the inspection, authorities discovered that the firm was stocking nine different varieties of allopathic medicines containing controlled substances Pregabalin and Alprazolam. These salts are subject to strict regulatory oversight due to their potential for misuse and addiction.
The establishment failed to produce mandatory purchase records for these medicines, which is a direct violation of the provisions under the Drugs and Cosmetics Act. This lack of documentation raised serious concerns about the legality of the stock and its potential diversion into illicit markets.
Immediate Seizure and Valuation
Consequently, authorities seized the medicines on the spot, with an estimated value of approximately Rs 47,640. This swift action underscores the department's commitment to enforcing drug laws and protecting public health from the risks associated with unregulated pharmaceuticals.
Navdeep Sandhu emphasized that strict action will be taken against such violations and confirmed that enforcement drives will continue unabated to curb illegal sales. He stated, "Our primary goal is to safeguard public health by ensuring that all pharmaceutical activities comply with the law. We will not tolerate any breaches that endanger community well-being."
Past Recoveries Highlight Ongoing Efforts
This recent case is part of a broader pattern of enforcement by the Drug Control Department. On March 17, a similar inspection was conducted at a pharmacy in New Chander Nagar. During that operation, the firm was found stocking four varieties of allopathic medicines containing Pregabalin.
Like the recent case, the establishment failed to produce the mandatory purchase records required under the Drugs and Cosmetics Act. Following the violation, medicines valued at approximately ₹23,408 were seized under the relevant provisions of the Act.
Key Points from the Crackdown
- The Drug Control Department acted on a tip-off to inspect a medical store in Ludhiana's Kaneja area.
- Nine varieties of allopathic medicines containing Pregabalin and Alprazolam were found without proper purchase records.
- Medicines worth Rs 47,640 were seized immediately due to violations of the Drugs and Cosmetics Act.
- Authorities have vowed to continue enforcement drives to prevent illegal sales and protect public health.
- This follows a previous seizure on March 17, where medicines worth ₹23,408 were confiscated in a similar case.
The intensified crackdown reflects the department's proactive approach in tackling the illegal pharmaceutical trade, which poses significant risks to public safety. By targeting non-compliant firms and seizing unauthorized stocks, the DCD aims to create a deterrent effect and ensure that all medical establishments adhere to regulatory standards.
